Amyloid‐β‐induced toxicity of primary neurons is dependent upon differentiation‐associated increases in tau and cyclin‐dependent kinase 5 expression

It has previously been reported that amyloid‐β (Aβ) peptide is neurotrophic to undifferentiated but neurotoxic to differentiated primary neurons. The underlying reasons for this differential effect is not understood. Recently, the toxicity of Aβ to neurons was shown to be dependent upon the activation of cyclin‐dependent kinase 5 (Cdk5), thought to promote tau phosphorylation that leads to cytoskeletal disruption, morphological degeneration and apoptosis. Here we report that Cdk5, tau, and phosphorylated‐tau (P‐tau) are expressed at very low levels in undifferentiated primary neurons, but that the expression of Cdk5 and tau and the phosphorylation of tau increase markedly between 4 and 8 days of differentiation in vitro. Tau expression decreased after this time, as did the level of P‐tau, to low levels by 17 days. Aβ induced tau phosphorylation of neurons only after ≥ 4 days of differentiation, a time that coincides with the onset of Aβ toxicity. Blocking tau expression (and therefore tau phosphorylation) with an antisense oligonucleotide completely blocked Aβ toxicity of differentiated primary neurons, thereby confirming that tau was essential for mediating Aβ toxicity. Our results demonstrate that differentiation‐associated changes in tau and Cdk‐5 modulate the toxicity of Aβ and explain the opposite responses of differentiated and undifferentiated neurons to Aβ. Our results predict that only cells containing appreciable levels of tau are susceptible to Aβ‐induced toxicity and may explain why Aβ is more toxic to neurons compared with other cell types.

[1]  Xudong Huang,et al.  Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42. , 2008, Journal of neurochemistry.

[2]  Matthew P. Frosch,et al.  Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[3]  I. Sponne,et al.  Apoptotic Neuronal Cell Death Induced by the Non-fibrillar Amyloid-β Peptide Proceeds through an Early Reactive Oxygen Species-dependent Cytoskeleton Perturbation* , 2003, The Journal of Biological Chemistry.

[4]  M. Mullan,et al.  p35/Cdk5 pathway mediates soluble amyloid‐β peptide‐induced tau phosphorylation in vitro , 2002, Journal of neuroscience research.

[5]  L. Tsai,et al.  A survey of Cdk5 activator p35 and p25 levels in Alzheimer's disease brains , 2002, FEBS letters.

[6]  K. Zou,et al.  A Novel Function of Monomeric Amyloid β-Protein Serving as an Antioxidant Molecule against Metal-Induced Oxidative Damage , 2002, The Journal of Neuroscience.

[7]  Xiantao Wang,et al.  Signaling Events in Amyloid β-Peptide-induced Neuronal Death and Insulin-like Growth Factor I Protection* , 2002, The Journal of Biological Chemistry.

[8]  M. Vitek,et al.  Tau is essential to β-amyloid-induced neurotoxicity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  E. Mandelkow,et al.  Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress , 2002, The Journal of cell biology.

[10]  L. Tsai,et al.  Calpain-mediated Cleavage of the Cyclin-dependent Kinase-5 Activator p39 to p29* , 2002, The Journal of Biological Chemistry.

[11]  C. Casal,et al.  Relationship between β-AP peptide aggregation and microglial activation , 2002, Brain Research.

[12]  M. A. Ajmone-Cat,et al.  Astrocytes contribute to neuronal impairment in βA toxicity increasing apoptosis in rat hippocampal neurons , 2001, Glia.

[13]  R. Maccioni,et al.  A Cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of Cdk5 activity in hippocampal neurons. , 2001, Experimental cell research.

[14]  Ashley I. Bush,et al.  Redox-active iron mediates amyloid-β toxicity , 2001 .

[15]  H. Soininen,et al.  β-Amyloid (1–42) affects MTT reduction in astrocytes: implications for vesicular trafficking and cell functionality , 2001, Neurochemistry International.

[16]  G. Johnson,et al.  Tau Protein Is Hyperphosphorylated in a Site‐Specific Manner in Apoptotic Neuronal PC12 Cells , 2000, Journal of neurochemistry.

[17]  P. Greengard,et al.  Neuron‐Specific Phosphorylation of Alzheimer's β‐Amyloid Precursor Protein by Cyclin‐Dependent Kinase 5 , 2000, Journal of neurochemistry.

[18]  R. Maccioni,et al.  Increase in the expression of the neuronal cyclin‐dependent protein kinase cdk‐5 during differentiation of N2A neuroblastoma cells , 2000, Neuroreport.

[19]  Xiongwei Zhu,et al.  Cyclin' toward dementia , 2000, Journal of neuroscience research.

[20]  Jerry H. Wang,et al.  The Expression of Cdk5, p35, p39, and Cdk5 Kinase Activity in Developing, Adult, and Aged Rat Brains , 2000, Neurochemical Research.

[21]  Xudong Huang,et al.  Evidence that the β-Amyloid Plaques of Alzheimer's Disease Represent the Redox-silencing and Entombment of Aβ by Zinc* , 2000, The Journal of Biological Chemistry.

[22]  D. Butterfield,et al.  Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity. , 2000, Journal of structural biology.

[23]  L. Tsai,et al.  Neurotoxicity induces cleavage of p35 to p25 by calpain , 2000, Nature.

[24]  Robert J. Cotter,et al.  Elevated Aβ42 in Skeletal Muscle of Alzheimer Disease Patients Suggests Peripheral Alterations of AβPP Metabolism , 2000 .

[25]  L. Tsai,et al.  Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration , 1999, Nature.

[26]  R. Maccioni,et al.  Inhibition of tau phosphorylating protein kinase cdk5 prevents β‐amyloid‐induced neuronal death , 1999, FEBS letters.

[27]  B. Volk,et al.  Inhibition of NF-kappaB potentiates amyloid beta-mediated neuronal apoptosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  E. Mandelkow,et al.  Mitotic phosphorylation of tau protein in neuronal cell lines resembles phosphorylation in Alzheimer's disease. , 1998, European journal of cell biology.

[29]  Bruce A. Yankner,et al.  Aging renders the brain vulnerable to amyloid β-protein neurotoxicity , 1998, Nature Medicine.

[30]  E. Mandelkow,et al.  The endogenous and cell cycle-dependent phosphorylation of tau protein in living cells: implications for Alzheimer's disease. , 1998, Molecular biology of the cell.

[31]  Xudong Huang,et al.  Dramatic Aggregation of Alzheimer Aβ by Cu(II) Is Induced by Conditions Representing Physiological Acidosis* , 1998, The Journal of Biological Chemistry.

[32]  J. Silver,et al.  Astrocytes Regulate Microglial Phagocytosis of Senile Plaque Cores of Alzheimer's Disease , 1998, Experimental Neurology.

[33]  D. Schubert,et al.  Cytotoxic Amyloid Peptides Inhibit Cellular 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) Reduction by Enhancing MTT Formazan Exocytosis , 1997, Journal of neurochemistry.

[34]  L. Tsai,et al.  Mice Lacking p35, a Neuronal Specific Activator of Cdk5, Display Cortical Lamination Defects, Seizures, and Adult Lethality , 1997, Neuron.

[35]  Richard Hollister,et al.  Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease , 1997, Annals of neurology.

[36]  M. Mattson,et al.  A Role for 4‐Hydroxynonenal, an Aldehydic Product of Lipid Peroxidation, in Disruption of Ion Homeostasis and Neuronal Death Induced by Amyloid β‐Peptide , 1997, Journal of neurochemistry.

[37]  Y. Ihara,et al.  τ Is Widely Expressed in Rat Tissues , 1996 .

[38]  J. Morris,et al.  Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease , 1996, The Journal of Neuroscience.

[39]  L. Tsai,et al.  The cdk5/p35 kinase is essential for neurite outgrowth during neuronal differentiation. , 1996, Genes & development.

[40]  M. Mullan,et al.  β-Amyloid-mediated vasoactivity and vascular endothelial damage , 1996, Nature.

[41]  B. Yankner,et al.  Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro , 1995, Nature.

[42]  D. Butterfield,et al.  A beta (25-35) peptide displays H2O2-like reactivity towards aqueous Fe2+, nitroxide spin probes, and synaptosomal membrane proteins. , 1995, Life sciences.

[43]  M. Memo,et al.  Differential expression of fetal and mature tau isoforms in primary cultures of rat cerebellar granule cells during differentiation in vitro. , 1995, Brain research. Molecular brain research.

[44]  J. Gallo,et al.  Tau isoform expression and phosphorylation state during differentiation of cultured neuronal cells , 1995, FEBS letters.

[45]  D. Butterfield,et al.  Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation , 1995, Journal of neurochemistry.

[46]  S. Pelech Networking with proline-directed protein kinases implicated in Tau phosphorylation , 1995, Neurobiology of Aging.

[47]  E. Vanmechelen,et al.  Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205 , 1995, Neuroscience Letters.

[48]  M. Mattson,et al.  Different amyloidogenic peptides share a similar mechanism of neurotoxicity involving reactive oxygen species and calcium , 1995, Brain Research.

[49]  B. Yankner,et al.  β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding , 1995, Neuron.

[50]  K. Jellinger,et al.  Decreased Catalase Activity but Unchanged Superoxide Dismutase Activity in Brains of Patients with Dementia of Alzheimer Type , 1995, Journal of neurochemistry.

[51]  S. Matsuyama,et al.  Tau‐like immunoreactivity in Alzheimer and control skin fibroblasts , 1994, Journal of neuroscience research.

[52]  M. Memo,et al.  Antisense strategy unravels tau proteins as molecular risk factors for glutamate-induced neurodegeneration , 1994, Cellular and Molecular Neurobiology.

[53]  P. Cohen,et al.  Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. , 1994, The Biochemical journal.

[54]  D. Selkoe,et al.  Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[55]  M. Vandermeeren,et al.  Microtubule-associated protein tau epitopes are present in fiber lesions in diverse muscle disorders. , 1994, The American journal of pathology.

[56]  N. Hirokawa,et al.  Altered microtubule organization in small-calibre axons of mice lacking tau protein , 1994, Nature.

[57]  J. McCarty,et al.  Sense and antisense transfection analysis of tau function: tau influences net microtubule assembly, neurite outgrowth and neuritic stability. , 1994, Journal of cell science.

[58]  W. Klein,et al.  Microtubule-Associated Protein Tau Is Hyperphosphorylated during Mitosis in the Human Neuroblastoma Cell Line SH-SY5Y , 1994, Experimental Neurology.

[59]  L. Tsai,et al.  Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. , 1993, Development.

[60]  J. Brion,et al.  Developmental Changes in τ Phosphorylation: Fetal τ Is Transiently Phosphorylated in a Manner Similar to Paired Helical Filament‐τ Characteristic of Alzheimer's Disease , 1993, Journal of neurochemistry.

[61]  J. Trojanowski,et al.  The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during development. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[62]  John Q. Trojanowski,et al.  Abnormal tau phosphorylation at Ser396 in alzheimer's disease recapitulates development and contributes to reduced microtubule binding , 1993, Neuron.

[63]  K. Imahori,et al.  τ Protein Kinase II Is Involved in the Regulation of the Normal Phosphorylation State of τ Protein , 1993 .

[64]  G. Cole,et al.  Vitamin E protects nerve cells from amyloid βprotein toxicity , 1992 .

[65]  G. Drewes,et al.  Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer‐like state. , 1992, The EMBO journal.

[66]  G. Lee,et al.  Expression of tau protein in non-neuronal cells: microtubule binding and stabilization. , 1992, Journal of cell science.

[67]  R. Liem,et al.  Primary structure of high molecular weight tau present in the peripheral nervous system. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[68]  R. Crowther,et al.  Cloning of a big tau microtubule-associated protein characteristic of the peripheral nervous system. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[69]  M. Mattson,et al.  beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[70]  M. Tabaton,et al.  Neuropil threads of Alzheimer's disease show a marked alteration of the normal cytoskeleton , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[71]  D. Kirschner,et al.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.

[72]  R. Tucker,et al.  The roles of microtubule-associated proteins in brain morphogenesis: a review , 1990, Brain Research Reviews.

[73]  C. Cotman,et al.  β-Amyloid protein promotes neuritic branching in hippocampal cultures , 1990, Neuroscience Letters.

[74]  N. Hirokawa,et al.  Expression of multiple tau isoforms and microtubule bundle formation in fibroblasts transfected with a single tau cDNA , 1989, The Journal of cell biology.

[75]  Kenneth S. Kosik,et al.  Developmentally regulated expression of specific tau sequences , 1989, Neuron.

[76]  C. Cotman,et al.  Amyloid beta protein enhances the survival of hippocampal neurons in vitro. , 1989, Science.

[77]  M. L. Schmidt,et al.  Distribution of tau proteins in the normal human central and peripheral nervous system. , 1989, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[78]  M. Kirschner,et al.  Regulation of microtubule protein levels during cellular morphogenesis in nerve growth factor-treated PC12 cells , 1988, The Journal of cell biology.

[79]  M. Kirschner,et al.  Tau protein function in living cells , 1986, The Journal of cell biology.

[80]  Sumire V. Kobayashi,et al.  Association of Tau Protein with Microtubules in Living Cells , 1986, Annals of the New York Academy of Sciences.

[81]  J. Ávila,et al.  Quantitation and characterization of tau factor in porcine tissues. , 1986, Biochimica et biophysica acta.

[82]  A. Frankfurter,et al.  The distribution of tau in the mammalian central nervous system , 1985, The Journal of cell biology.

[83]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[84]  G. Glenner,et al.  Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .

[85]  INTERNATIONAL SOCIETY FOR NEUROCHEMISTRY , 1976 .

[86]  K. Imahori,et al.  Tau protein immunoreactivity in muscle fibers with rimmed vacuoles differs from that in regenerating muscle fibers , 2004, Acta Neuropathologica.

[87]  Yasuo Ihara,et al.  Muscle fiber degeneration in distal myopathy with rimmed vacuole formation , 2004, Acta Neuropathologica.

[88]  D. Selkoe,et al.  Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[89]  C. Casal,et al.  Relationship between beta-AP peptide aggregation and microglial activation. , 2002, Brain research.

[90]  M. Vitek,et al.  Tau is essential to beta -amyloid-induced neurotoxicity. , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[91]  R. Maccioni,et al.  AbetaPP induces cdk5-dependent tau hyperphosphorylation in transgenic mice Tg2576. , 2002, Journal of Alzheimer's disease : JAD.

[92]  M. Smith,et al.  Redox-active iron mediates amyloid-beta toxicity. , 2001, Free radical biology & medicine.

[93]  S. Schippling,et al.  Amyloid-beta is an antioxidant for lipoproteins in cerebrospinal fluid and plasma. , 2001, Free radical biology & medicine.

[94]  S. Arlt,et al.  Amyloid-β is an antioxidant for lipoproteins in cerebrospinal fluid and plasma , 2001 .

[95]  T. Beach,et al.  Elevated abeta42 in skeletal muscle of Alzheimer disease patients suggests peripheral alterations of AbetaPP metabolism. , 2000, The American journal of pathology.

[96]  R. Martins,et al.  Anti-apoptotic action of Alzheimer Ab , 1999 .

[97]  Xudong Huang,et al.  ANTI-APOPTOTIC ACTION OF ALZHEIMER BETA AMYLOID , 1999 .

[98]  C. Geula,et al.  Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity. , 1998, Nature medicine.

[99]  W R Markesbery,et al.  Oxidative stress hypothesis in Alzheimer's disease. , 1997, Free radical biology & medicine.

[100]  M. Mullan,et al.  beta-Amyloid-mediated vasoactivity and vascular endothelial damage. , 1996, Nature.

[101]  G. Perry,et al.  beta PP and Tau interaction. A possible link between amyloid and neurofibrillary tangles in Alzheimer's disease. , 1996, The American journal of pathology.

[102]  Y. Ihara,et al.  Tau is widely expressed in rat tissues. , 1996, Journal of Neurochemistry.

[103]  M. Mattson,et al.  Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease. , 1996, Molecular neurobiology.

[104]  C. Behl,et al.  Hydrogen peroxide mediates amyloid beta protein toxicity. , 1994, Cell.

[105]  K. Imahori,et al.  Tau protein kinase II is involved in the regulation of the normal phosphorylation state of tau protein. , 1993, Journal of neurochemistry.

[106]  G. Cole,et al.  Vitamin E protects nerve cells from amyloid beta protein toxicity. , 1992, Biochemical and biophysical research communications.

[107]  K. Boekelheide,et al.  Tau, the neuronal heat-stable microtubule-associated protein, is also present in the cross-linked microtubule network of the testicular spermatid manchette. , 1992, Biology of reproduction.

[108]  Papasozomenos Sc Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications. , 1989 .

[109]  S. Papasozomenos Tau protein immunoreactivity in dementia of the Alzheimer type. I. Morphology, evolution, distribution, and pathogenetic implications. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[110]  L. Binder,et al.  Phosphorylation determines two distinct species of Tau in the central nervous system. , 1987, Cell motility and the cytoskeleton.

[111]  G. Glenner,et al.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. , 1984, Biochemical and biophysical research communications.